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Inadequate collateral formation in the heart in diabetic (DM) animals
and patients was considered to be partly caused by a decrease in
vascular endothelial growth factor (VEGF), the key angiogenic factor.
The present study was designed to investigate the therapeutic
implication to improve the defect in VEGF signaling in DM hearts by
ET antagonists. We investigated whether ET-A/B dual receptor antago-
nist (SB209670, 1 mg/kg/day) and ET-A receptor antagonist (TA-0201,
1 mg/kg/day) would reverse the downregulated VEGF signaling in early
streptozotocin (STZ)-induced diabetic hearts with no obvious cardiac
dysfunction in echocardiography. Male Sprague–Dawley rats were
administered citrate saline (vehicle) or STZ (65 mg/kg IP). One week
after the injection, animals were separated into those receiving
SB209670, TA-0201 or vehicle by osmotic mini pump for 2 weeks.
Cardiac ET-1 level was signiﬁcantly increased in DM than in non-DM
rats and SB209670 treatment greatly reversed the higher ET-1 levels in
DM heart than those by the TA-0201 treatment. VEGF level in DM
heart was signiﬁcantly decreased than in non-DM rats, SB209670 and
TA-0201 treatments completely prevented this VEGF downregulation in
DM hearts. The dual ET-A/B receptor blocker was more effective in
reversing the alterations in phosphorylated Akt and eNOS, the two
important downstreams of VEGF angiogenic signaling, in DM heart than
the ETA-receptor antagonist. In conclusion, ET antagonism is effective in
preventing the downregulation of VEGF in diabetic heart, and the dual
ET-A/B receptor antagonist and the selective ETA receptor antagonist
were effective in ameliorating the decreased VEGF signaling and
inadequate coronary collateral development in diabetic hearts.
doi:10.1016/j.lfs.2014.01.022
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Background: Endothelin-1 (ET-1) is implicated in the development
and progression of chronic kidney disease (CKD). It has also been linked
to increased cardiovascular risk in patients with CKD. Here we
evaluated plasma levels of endothelin-like domain peptide (ELDP;
preproET-1[93–166]) and CT-proET-1 (preproET-1[169–212]) in pa-
tients with proteinuric CKD after treatmentwith sitaxentan. Changes in
proET-1 peptides were compared with various parameters of cardio-
vascular and renal function. Methods and results: Twenty-seven
patients with proteinuric CKD receiving recommended renoprotective
treatment were randomised to 6 weeks of placebo, sitaxentan (100 mg
once daily), and nifedipine long-acting (30 mg once daily), in a double-
blind, three-way crossover study design. Renal and cardiovascular
function, and plasma biomarkers were measured at baseline, week 3,
and week 6 of each treatment period. ELDP and CT-proET-1 were
measured by speciﬁc sandwich ELISAs. Sitaxentan treatment resulted in
signiﬁcant increases in ELDP and CT-proET-1 at both 3 and 6 weeks
compared to baseline (mean increases % ± sem at 3 and 6 weeks:
ELDP +17.5 ± 3.2, +15.0 ± 3.5; CT-proET-1 + 12.9 ± 2.0, +14.4
± 2.6; p b 0.001 for all values). Placebo and nifedipine had no effect
on plasma ELDP and CT-proET-1. After 6 weeks sitaxentan plasma ELDP
and CT-proET-1 were negatively correlated with 24 h urinary Na+
excretion (p= 0.015, r2 = 0.2149; p = 0.013, r2 = 0.2227, respec-
tively). Conclusions: Increases in proET-1 biomarkers after sitaxentan
indicate that ETA antagonists block a negative feedback effect of ET-1 on
EDN1 gene expression that is mediated via ETA receptors. The inverse
relationship between plasma proET-1 biomarkers and urinary Na+
excretion after sitaxentan requires further investigation.
doi:10.1016/j.lfs.2014.01.023
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Aging is a main risk factor for carotid artery disease and stroke.
The constrictor peptides endothelin-1 and angiotensin II are
important modiﬁers of age-induced vascular diseases, partly through
altered activity of NADPH oxidase (Nox)-derived superoxide and
constrictor prostanoids. Whether aging affects Nox- or prostanoid-
mediated constrictor responses to endothelin-1 or angiotensin II in
carotid arteries is unknown. We studied contractions to endothelin-1
(0.1–100 nmol/L) and angiotensin II (100 nmol/L) in isolated com-
mon carotid artery rings from young and old C57BL6 mice (4 and
24 months of age). The nitric oxide synthase inhibitor l-NAME
(300 μmol/L) was used throughout the study to exclude endothelin
ETB receptor- or angiotensin AT2 receptor-mediatednitric oxide release
during contractions, which are given relative to KCl (60 mmol/L)-
induced responses. Some arteries were additionally incubated with the
Nox- speciﬁc inhibitor gp91ds-tat (3 μmol/L) or the thromboxane-
prostanoid receptor antagonist SQ 29′548 (1 μmol/L) for 30 min. Aging
markedly reducedmaximal responses (Emax) and the sensitivity (pD2)
to endothelin-1 (Emax 8.9 ± 1.8% vs. 26.2 ± 3.8%, 3-fold, P b 0.001;
pD28.02 ± 0.07 vs. 8.54 ± 0.02, P b 0.01). Inhibition of Nox activity
blunted endothelin-1-induced contractions by 42% and 63% in young
and old animals, respectively (P b 0.05), while the thromboxane-
prostanoid receptor antagonist had no effect in either group. Contrac-
tions to angiotensin II were weak in young and old animals (3.6 ± 0.4%
vs. 3.1 ± 0.2%, P = n.s.) and unaffected by gp91ds-tat or SQ 29′548. In
summary, aging selectively impairs contractions to endothelin-1 in
carotid arteries, which depend on Nox activity, but not on constrictor
prostanoids. Endothelin-1 but not angiotensin II seems to be involved in
functional aging of carotid arteries.
doi:10.1016/j.lfs.2014.01.024
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Introduction. Inﬂammation is thought to be one of themajor factors
in the progression of arrhythmogenic atrial remodeling that promote
atrial ﬁbrillation (AF). The aim of this study was to investigate the
effects of inﬂammatory state before and immediately after catheter
ablation on clinical outcomes after catheter ablation of persistent AF.
Methods. We investigated 176 patients with long-standing persistent
AF (sustained AF duration; 1 to 20 years, with a mean of 3.4 ±
3.8 years) undergoing catheter ablation. The high-sensitivity C-reactive
protein (hs-CRP) levelwasmeasured as an inﬂammatorymarker before
and immediately after the catheter ablation. Patients were divided into
two groups according to the hs-CRP level in the baseline: high hs-CRP
group (n= 84, N0.075 mg/dl) and low hs-CRP group (n= 92,
b0.075 mg/dl). Results. Catheter ablation was successfully performed
in all patients. After 12-month follow-up, 53.4% of the patients had AF
recurrence. The hs-CRP level before catheter ablation was signiﬁcantly
associated with AF recurrence (p= 0.024), however, neither the hs-
CRP level immediately after catheter ablation nor the increment of hs-
CRP after catheter ablation was not associated with AF recurrence.
Multivariate Cox regression analysis revealed that longer duration of AF
(p b 0.001), larger left atrial diameter (p= 0.049), and higher hs-CRP
level (p= 0.033) were signiﬁcantly associated with AF recurrence. In
Kaplan–Meier AF free curves, there is a signiﬁcant difference in AF free
rates between lowhs-CRP group (57% at 1 year) and high hs-CRP group
(35% at 1 year) (p= 0.007). Conclusions. The increased hs-CRP level
reﬂecting an inﬂammatory state before catheter ablation may is one of
the important predictors of recurrence of AF after catheter ablation in
patients with long-standing persistent AF.
doi:10.1016/j.lfs.2014.01.025
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Because the parietal pericardium is opened during cardio-thoracic
surgeries, the tissue might be used for translational research. We
investigated whether i) contractile resistance-sized arteries can be
isolated from the parietal pericardium and ii) whether their arterial
smooth muscle is responsive to endothelin (ET). Tissue was harvested
from pigs i) in a local slaughterhouse (N= 8) or ii) at the end of
experimental surgery under a cocktail of anaesthetics and analgesics
(N= 7) and stored overnight. Arterial segments were microdissected
from the tissue and studied inwiremyographs. Arterial lumendiameter
at a distending pressure of 100 mmHg was 251 ± 24 μm. Contraction
in response to 32 mM K+ averaged 3.9 ± 0.9 N/m. Responses to ET-
receptor stimulation were investigated after desensitization of senso-
rimotor nerves and irreversible blockade of α-adrenergic receptors
and in the continuous presence of inhibitors of NO synthases,
cyclooxygenases and small- and intermediate-conductance Ca2+-
activated K+ channels. These pharmacological tools were applied to
concentrate on arterial smooth muscle responses. Sarafotoxin 6c
(ETB-agonist) caused potent and strong contractions (EC50 42 pM,
Emax 4.1 ± 0.3 N/m). Thereafter and in the presence of 30 nMA-192621
(ETB-antagonist) the sensitivity and maximal contractile response to
ET-1 averaged 1.3 nM and 8.5 ± 2.4 N/m, respectively. 100 nM PD-
156707 (ETA-antagonist) reduced the sensitivity and maximal response
to ET-1 in these conditions. Differences between arteries from both
sources were not statistically signiﬁcant. We conclude that resistance
arteries from the parietal pericardium of patients undergoing cardio-
thoracic surgerymay be useful for translational studies of arterial smooth
muscle responses to ETA- and ETB-receptor stimulation and blockade.
doi:10.1016/j.lfs.2014.01.026
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Acute arterial occlusion due to an embolus or a thrombus causes
hypoxia in the vascular bed, usually resulting in critical injury. Hypoxia
affects more or less vascular function, but the response to low oxygen
differs in individual vascular beds. The present study examined the
inﬂuence of hypoxia on endothelin-1 (ET-1)-induced contraction in
isolated rat carotid andmesenteric arteries. Although the addition of ET-1
(10−10 to 10−8 M) produced a dose-dependent contraction either in
carotid or mesenteric arteries, the response to ET-1 was signiﬁcantly
attenuated by hypoxia in carotid, but not in mesenteric, arteries. The
impaired contraction to ET-1 in carotid arteries was also observed in
endothelium-denudated preparations or in the presence of an endothelin
type B (ETB) receptor antagonist (BQ-788, 10−6 M). Meanwhile, ET-1-
induced contraction of carotid arteries in the presence of an endothelin
type A (ETA) receptor antagonist (BQ-123, 10−6 M) was not affected by
hypoxia. Incidentally, ET-1-induced contraction was largely inhibited by
antagonism of ETA receptors either in carotid or mesenteric arteries. In
addition, IRL-1620 (b10−7 M), a selective ETB receptor agonist, did not
cause any contraction in both arteries. Although a crucial feature of the
response to hypoxia is to produce reactive oxygen species like
superoxide, the treatment with superoxide dismutase (200 U/mL) did
not affect the inﬂuence of hypoxia on ET-1-induced contraction in both
arteries. These ﬁndings suggest that although ET-1 induces contraction
through ETA receptors either in carotid or mesenteric arteries, hypoxia
impairs this pathway only in carotid arteries. Furthermore, extracellular
superoxide seems not to be a causal factor responsible for this regional
difference.
doi:10.1016/j.lfs.2014.01.027
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Preclinical studies indicate that the renal endothelin system is
involved in the pathogenesis of acute renal failure. Contrast media
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